(Q44357651)

2 December 2017

title

Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). (English)

1 reference

2 December 2017

1 reference

J Van Cutsem

1

1 reference

2 December 2017

J R Boelaert

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

2 December 2017

1 reference

2 December 2017

volume

36

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

1061-1068

1 reference

Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Fatal phycomycosis in a hemodialyzed patient receiving deferoxamine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Opportunistic zygomycotic infections. A literature review

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Deferoxamine does not increase the risk for bacteremia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Experimental zygomycosis due to Rhizopus spp. infection by various routes in guinea-pigs, rats and mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1989.301

1 reference

7 January 2021

The Role of Ascorbic Acid in the Metabolism of Storage Iron

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Fungistatic capacity of sera from guinea pigs injected with various iron solutions: differences between Trichophyton mentagrophytes and Rhizopus oryzae.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

High-performance liquid chromatography of siderophores from fungi

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Factors determining the susceptibility of mice to experimental phycomycosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Cunninghamella bertholletiae infection associated with deferoxamine therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Deferoxamine treatment as a risk factor for zygomycete infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Dealing with uncertainty, risks, and tradeoffs in clinical decisions. A cognitive science approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Effect of an iron-chelating agent on lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Hydroxyl radical mediation of immune renal injury by desferrioxamine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Immuno-modulation of human lymphocyte function by desferroxamine (Desferal)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.301

7 January 2021

Identifiers

DOI

10.1038/KI.1989.301

1 reference

2 December 2017

1 reference